PD-1 and PD-L1 expression in rare lung tumors

Gyulai, Marton [Gyulai, Márton (tüdőgyógyászat), author] School of PhD Studies (SU); Megyesfalvi, Zsolt [Megyesfalvi, Zsolt (Orvostudomány), author] National Institute of Oncology; Department of Thoracic Surgery (SU / FM / C); Reiniger, Lilla [Reiniger, Lilla (Neuropatológia), author] Patológiai és Kísérleti Rákkutató Intézet (SU / FM / I); Harko, Tunde; Ferencz, Bence [Ferencz, Bence (Klinikai orvostud...), author] National Institute of Oncology; Department of Thoracic Surgery (SU / FM / C); Karsko, Luca; Agocs, Laszlo [Agócs, László (Mellkassebészet), author] National Institute of Oncology; Department of Thoracic Surgery (SU / FM / C); Fillinger, Janos [Fillinger, János (patológia), author]; Dome, Balazs [Döme, Balázs (Tumor indukált an...), author] National Institute of Oncology; Department of Thoracic Surgery (SU / FM / C); Szallasi, Zoltan [Szállási, Zoltán (Onkológia, dagana...), author] Bioinformatika Tanszék (SU / FM / I); Moldvay, Judit ✉ [Moldvay, Judit (Tüdõgyógyászat), author] Koranyi National Institute for Pulmonology

English Article (Journal Article) Scientific
Published: PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 29 Paper: 1611164 , 9 p. 2023
  • SJR Scopus - Medicine (miscellaneous): Q2
Identifiers
Fundings:
  • (ÚNKP-20-3)
  • (UNKP-21-3)
  • (Hungarian Respiratory Society (MPA #2020))
  • Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009) Funder: EFOP-VEKOP
  • (KH130356)
  • (K129065)
  • (KNN121510)
  • (K129065)
  • (2017-1.2.1-NKP-2017-00002.)
Subjects:
  • Oncology
  • Pathology
Background: Our knowledge is still limited about the characteristics and treatment of rare lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) and programmed cell death-1 (PD-1) expression in rare pulmonary tumors to assess the potential role of immunotherapy.
Cited in (3)
Citing (5)
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-07 05:48